Quality of life as a criterion of disease modifying anti-rheumaticdrug and biological agents therapy efficacy: results of international and Russian studies

Quality of life as a criterion of disease modifying anti-rheumaticdrug and biological agents therapy efficacy: results of international and Russian studies

Bibliographic Details
Main Authors:	V N Amirdjanova, E Y Kaigorodtseva, N A Savenkova, E L Nasonov
Format:	Article
Language:	Russian
Published:	IMA PRESS LLC 2009-04-01
Series:	Научно-практическая ревматология
Online Access:	https://rsp.mediar-press.net/rsp/article/view/598

Similar Items

Quality of life in patients with rheumatoid arthritis receiving anti-В cell therapy (results of international studies and Russia registry)
by: V N Amirdjanova, et al.
Published: (2008-12-01)

Russian registry of patients receiving rituximab: results of pharmacoeconomic analysis
by: V N Amirdjanova, et al.
Published: (2009-02-01)

Safety of using genetic engineering biological agents in rheumatoid arthritis
by: N V Chichasova, et al.
Published: (2010-03-01)

DEVELOPMENTS OF RUSSIAN ORIGINAL BIOLOGICAL AGENTS FOR THE TREATMENT OF IMMUNOINFLAMMATORY RHEUMATIC DISEASES
by: E. L. Nasonov, et al.
Published: (2017-04-01)

EFFICACY OF ETANERCEPT IN PATIENTS WITH RHEUMATOID ARTHRITIS (results of the Russian multicenter ETALON study)
by: Anna Olegovna Pchelintseva, et al.
Published: (2014-02-01)

SAFETY OF CANNED MILK AS AN INTEGRATED CRITERION OF THEIR TECHNOLOGY EFFECTIVENESS. RUSSIAN EXPERIENCE
by: S. N. Turovskaya, et al.
Published: (2018-07-01)

Fairchild and the Single Agent Criterion
by: Green, S
Published: (2017)

Validation of general questionnaire EuroQol-5D (EQ-5D) Russian version
by: V N Amirdjanova, et al.
Published: (2007-06-01)

Combination therapy with leflunomide and genetic engineering biological agents
by: Nataliya Vladimirovna Chichasova, et al.
Published: (2011-06-01)

Perspectives of Quality of Life improvement in patients with rheumatoid arthritis with administration of fully human anti-tumor necrosis factor alpha monoclonal antibodies
by: V N. Amirdjanova
Published: (2008-06-01)

USE OF GENETICALLY ENGINEERED BIOLOGICAL DRUGS FOR RHEUMATOID ARTHRITIS IN THE RUSSIAN FEDERATION
by: Rimma Mikhailovna Balabanova, et al.
Published: (2012-12-01)

THE EFFICACY AND SAFETY OF RITUXIMAB BIOSIMILAR (ACELLBIA®) IN RHEUMATOID ARTHRITIS AS THE FIRST BIOLOGICAL AGENT: RESULTS OF PHASE III (ALTERRA) CLINICAL TRIAL
by: E. L. Nasonov, et al.
Published: (2017-09-01)

USE OF THE NEW GENETIC ENGINEERING BIOLOGICAL AGENT TOCILIZUMABIN THE TREATMENT OF RHEUMATOID ARTHRITIS
by: E L Nasonov, et al.
Published: (2010-03-01)

TREATMENT WITH GENETICALLY ENGINEERED BIOLOGICAL AGENTS: EFFICACY AND SAFETY OF CHANGEOVER
by: A. A. Baranov, et al.
Published: (2014-01-01)

Russian registry of Infliximab.Impact of therapy on the functional status of patients with rheumatoid arthritis
by: V N Amirdzhanova, et al.
Published: (2010-12-01)

The duration of remission and minimal disease activity after initiation and discontinuation of biological agents in patients with early psoriatic arthritis (data from the all-russian psoriatic arthritis registry)
by: E. Yu. Loginova, et al.
Published: (2019-11-01)

IMPACT OF THERAPY WITH BIOLOGICAL AGENTS ON B-LYMPHOCYTE SUBPOPULATIONS IN RHEUMATIC DISEASES: NEW EVIDENCE
by: E. V. Suponitskaya, et al.
Published: (2015-03-01)

EFFECTS OF SYNTHETIC DISEASE-MODIFYING ANTIRHEUMATIC DRUGS, BIOLOGICAL AGENTS, AND PSYCHOPHARMACOTHERAPY ON THE MENTAL DISORDERS IN PATIENTS WITH RHEUMATOID ARTHRITIS
by: A. A. Abramkin, et al.
Published: (2017-09-01)

Genetically engineered biological agents in therapy for systemic lupus erythematosus
by: Elena Aleksandrovna Aseeva, et al.
Published: (2013-10-01)

Complications after endoprosthetic joint replacement in patients receiving genetically engineered biological agents
by: Elena Yuryevna Pogozheva, et al.
Published: (2012-06-01)

Developing anti-TNF and biologic agents.
by: Taylor, P
Published: (2011)

Russian Federation regions classification according to criterion of self-developing
by: Ekaterina Aleksandrovna Zakharchuk, et al.
Published: (2011-09-01)

Factors affecting the results of analgesic therapy. Results of the Russian multicentre study of NOTE (NSAID: Open-label Trial of Efficacy)
by: A E Karateev, et al.
Published: (2018-06-01)

Effect of biological agents on B-lymphocyte subpopulations in patients with systemic lupus erythematosus
by: A. A. Mesnyankina, et al.
Published: (2019-03-01)

Use of genetically engineered biological agents for the treatment of rheumatoid arthritis: general characteristics (a lecture)
by: Evgeni Lvovich Nasonov, et al.
Published: (2013-04-01)

A modified failure criterion for transversely isotropic rocks
by: Omid Saeidi, et al.
Published: (2014-03-01)

Immunological effects of adalimumab in rheumatoid arthritis: Results of a Russian national study
by: Dmitri Evgenyevich Karateev, et al.
Published: (2013-06-01)

Pharmacoeconomic analysis of using biological agents for uncontrolled moderate-to-severe atopic asthma in the Russian Federation
by: S. K. Zyryanov, et al.
Published: (2020-02-01)

Two-Criterion Model of the Russian Society Stratification by Income and Housing Security
by: Vyacheslav Nikolaevich Bobkov, et al.
Published: (2018-12-01)

Relative Efficacy and Safety of Anti-Inflammatory Biologic Agents for Osteoarthritis: A Conventional and Network Meta-Analysis
by: Yang Li, et al.
Published: (2022-07-01)

EFFICACY AND SAFETY OF ANTI-TNFα HUMAN MONOCLONAL ANTIBODIES IN CHILDREN WITH JUVENILE IDIOPATHIC ARTHRITIS AND SECONDARY RESISTANCE TO OTHER GENETICALLY ENGINEERED BIOLOGICAL AGENTS
by: E. I. Alexeeva, et al.
Published: (2012-07-01)

ON THE COMPARISON OF BAYESIAN INFORMATION CRITERION AND DRAPER'S INFORMATION CRITERION IN SELECTION OF AN ASYMMETRIC PRICE RELATIONSHIP: BOOTSTRAP SIMULATION RESULTS
by: Henry de-Graft Acquah, et al.
Published: (2013-03-01)

The criterion for space-age organization of stand
by: Dmitry E Kislov, et al.
Published: (2012-03-01)

On the hodological criterion for homology
by: Macarena eFaunes, et al.
Published: (2015-06-01)

Substantiation of Proposals on Improvement of Normative and Legal Regulation in the Field of Pathogenic Biological Agents Handling in the Russian Federation
by: M. N. Lyapin, et al.
Published: (2013-03-01)

Modified BIC Criterion for Model Selection in Linear Mixed Models
by: Hang Lai, et al.
Published: (2023-05-01)

Efficacy of genetically engineered biological agents in the treatment of uveitis associated with rheumatic diseases in children
by: V V Neroyev, et al.
Published: (2012-08-01)

PHARMACOTHERAPY FOR RHEUMATOID ARTHRITIS: RUSSIAN AND INTERNATIONAL GUIDELINES
by: E. L. Nasonov
Published: (2016-12-01)

Magnetic resonance tomography capabilities and limitations in managing the efficacy of treatment with biological disease modifying anti-rheumatic drugs in ankylosing spondylitis
by: P. A. Shesternya, et al.
Published: (2021-04-01)

Advances in rheumatology at the beginning of the 21st century
by: E. L. Nasonov, et al.
Published: (2022-03-01)